Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation

16 Nov 2022

Abstract excerpt

BACKGROUND: There is large individual variation in both clinical presentation and progression between Parkinson's disease patients. Generation of deeply and longitudinally phenotyped patient cohorts has enormous potential to identify disease subtypes for prognosis and therapeutic targeting. METHODS: Replicating across three large Parkinson's cohorts (Oxford Discovery cohort (n = 842)/Tracking UK Parkinson's study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neuroinflammation and Neurodegeneration Mechanisms
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36384636
DOI: 10.1186/s13073-022-01132-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammationPMID 36384636Read ↗

Universal latent axes capturing Parkinson’s patient deep phenotypic variation reveals patients with a high genetic risk for Alzheimer’s disease are more likely to develop a more aggressive form of Parkinson’sSemantic proximity Read ↗

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohortsSemantic proximity Read ↗

Genetically-Informed Prediction of Short-Term Parkinson’s Disease ProgressionSemantic proximity Read ↗

Genome-wide association study of Parkinson’s disease progression biomarkers in 12 longitudinal patients’ cohortsSemantic proximity Read ↗

Parkinson’s Disease motor and non-motor progression models emerge from pathway-level transcriptomicsSemantic proximity Read ↗

Parkinson's Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort.Semantic proximity Read ↗

<p class="MDPI13authornamesori1" style="margin-bottom: 12.0pt; mso-line-height-alt: 14.0pt;">Genetic Associations of Parkinson’s Disease Clinical, Pathological, and Data-driven SubtypesSemantic proximity Read ↗

Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).Semantic proximity Read ↗

Constructing Parkinson's disease progression- endotype molecular networks for drug repurposing: multi-omics evidence aggregation and large-scale real-world data validationSemantic proximity Read ↗

Changes in the cerebrospinal fluid proteome precede and stratify the course of Parkinson’s DiseaseSemantic proximity Read ↗

Parkinson’s disease causality and heterogeneity: a proteogenomic viewSemantic proximity Read ↗

Polygenic risk score-based prediction for Parkinson’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.